ARS Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 61.45M281.44M233.19M351.15M
Current Assets
Cash & Equivalents 60.06M210.52M70.97M50.82M
Short-term Investments 63.86M157.39M263.20M
Cash & Current Investments 60.06M274.38M228.36M314.02M
Receivables - Net 8.18M
Receivables - Other 0.16M0.21M0.65M1.23M
Receivables 9.41M
Finished Goods 5.21M
Inventory 5.21M
Prepaid Assets 0.67M3.32M3.37M6.89M
Current Assets 60.73M277.70M231.73M334.30M
Non-Current Assets
Property, Plant & Equipment (Net) 0.07M0.33M0.57M1.03M
Long-Term Investments 64.78M
Intangibles 0.62M7.37M
Goodwill & Intangibles 0.62M7.37M
Long-Term Deferred Tax 29.04M36.86M
Other Non-Current Assets 0.02M2.96M0.64M3.11M
Non-Current Assets 0.72M3.73M1.46M16.86M
Liabilities
Current Liabilities
Accounts Payables 3.11M4.93M2.15M22.84M
Notes Payables 3.48M
Payables 6.59M4.93M2.15M22.84M
Accumulated Expenses 11.73M2.29M
Other Accumulated Expenses 0.57M
Current Leases 0.14M0.23M0.24M0.04M
Current Deferred Revenue 1.46M3.14M0.56M
Total Current Liabilities 8.19M5.44M2.39M23.44M
Non-Current Liabilities
Non-Current Debt 4.93M
Non-Current Deffered Revenue 3.00M2.85M1.53M
Preferred Stock Liabilities 54.81M
Operating Leases 0.48M0.25M0.04M
Other Non-Current Liabilities 0.08M
Total Non-Current Liabilities 16.59M
Liabilities
Total Liabilities 16.68M8.55M2.43M94.36M
Shareholder's Equity
Total Debt 4.93M
Common Equity -31.27M272.89M230.76M256.80M
Shareholder's Equity -31.27M272.89M230.76M256.80M
Liabilities and Shareholders Equity 61.45M281.44M233.19M351.15M
Retained Earnings -42.26M-76.94M-131.30M-123.31M